-
12m 52sPart 1 | Session 4 MANIFEST-REDO: Re-Do Procedures After PFA for AF
-
7m 16s
-
6m 24sPart 2 | Session 1 4 Trials That Will Change My Practice With Dr Luigi Di Biase
-
3m 5sPart 2 | Session 2 Highlights with Dr Ronghua Yang
-
3m 3sPart 1 | Session 2 Balloon-Based PFA for De Novo PVI in PAF and PersAF
AF Symposium 25 — The retrospective study using data from the admIRE trial (NCT05293639) suggests the occurrence of premature ventricular complexes (PVCs) early after atrial fibrillation (AF) ablation is a marker of increased risk of recurrent atrial arrhythmias.
In this interview, Dr William Whang (The Mount Sinai Hospital, New York, US) joins us onsite at AF Symposium 25 to discuss the study investigating whether PVCs after catheter ablation for paroxysmal AF can be used to predict recurrent atrial arrhythmias. Patients with paroxysmal AF from retrospective cohorts of admIRE, a multicenter, single-arm trial, were enrolled in the study and underwent weekly and then monthly transtelephonic monitoring.
Findings showed participants with early PVCs detected after PFA for PAF were at higher risk for recurrent atrial arrhythmias than patients who didn't have early PVCs.
Interview Questions:
1. What is the background of AdmIRE?
2. What was the study design and patient population?
3. What are the key findings?
4. What are your key take-home messages?
5. What further study is needed?
Recorded onsite at AF Symposium in Boston, 2025.
Editors: Yazmin Sadik, Jordan Rance
Videographers: Oliver Miles, David Ben-Harosh
Interviewer: David Ramsey
Support: This is an independent interview produced by Arrhythmia Academy.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2025 in Boston. Don't miss our short, accessible Expert Interviews and Highlights of the most pertinent trials.
More from this programme
Faculty Biographies
William Whang
Clinical Cardiac Electrophysiologist
Dr William Whang is a Clinical Cardiac Electrophysiologist at The Mount Sinai Hospital in New York, specialising in catheter ablation procedures and device implantation.
Having graduated from Harvard college and achieving an MD from Columbia University, Dr Whang went on to complete cardiology and cardiac electrophysiology fellowships at Massachusetts General Hospital.
He has previously served as Director of the Holter lab and an Advisory Board Member for the Patient Oriented Research Masters Degree Program at Columbia University Medical Center. Since then, Dr Whang has been repeatedly recognized as one of New York Magazine's Top Doctors.
Comments